An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis
Inhaled antibiotic nanoparticles have emerged as an effective strategy to control infection in bronchiectasis lung owed to their mucus-penetrating ability. Using ciprofloxacin (CIP) as the model antibiotic, we evaluated dry powder inhaler (DPI) formulations of two classes of antibiotic nanoparticles...
Saved in:
Main Authors: | Tran, The-Thien, Yu, Hong, Vidaillac, Celine, Lim, Albert Y. H., Abisheganaden, John A., Chotirmall, Sanjay Haresh, Hadinoto, Kunn |
---|---|
Other Authors: | School of Chemical and Biomedical Engineering |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/144358 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
A new therapeutic avenue for bronchiectasis : dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart
by: Tran, The-Thien, et al.
Published: (2020) -
Ternary nanoparticle complex of antibiotic, polyelectrolyte, and mucolytic enzyme as a potential antibiotic delivery system in bronchiectasis therapy
by: Tran, The-Thien, et al.
Published: (2022) -
Antibiotics Used in Regenerative Endodontics Modify Immune Response of Macrophages to Bacterial Infection
by: En En Tan, et al.
Published: (2022) -
Development of mucus-penetrating antibiotic and quorum sensing inhibitor nanoparticle complex for bronchiectasis therapy
by: Tran, The Thien
Published: (2020) -
Liposomal carrier systems for encapsulation of vitamins using bicellar mixture
by: Lim, May Zhi Qing
Published: (2024)